RIPA buffer augmented with protease and phosphatase inhibitors was administered for cell lysis (14 (link)). The proteins were separated by SDS-PAGE and then transferred to nitrocellulose blotting membranes (GE Healthcare Life Science, Germany). The spots were examined with antibodies against PARP (Cell Signaling Technology, CST, Danvers, MA, USA, 9542), vinculin (Abcam, Cambridge, MA, USA, ab129002), GAPDH (HUABIO, Woburn, MA, USA, M1310-2), ATM (Santa Cruz Biotechnology, Dallas, TX, USA, sc135663), p-ATM (Ser1981) (CST, 5883), H2AX (Santa Cruz Biotechnology, sc517336), p-H2AX (Ser139) (Santa Cruz Biotechnology, sc517348), CHK1 (Santa Cruz Biotechnology, sc8408), p-CHK1 (Ser345) (CST, 2348), P53 (Santa Cruz Biotechnology, sc126), p-P53 (Ser15) (CST, 9286), ATR (Santa Cruz Biotechnology, sc515173), p-ATR (Ser428) (CST, 2853), FANCD2 (Santa Cruz Biotechnology, sc20022), and RAD51 (Santa Cruz Biotechnology, sc398587).
Free full text: Click here